SCHEDULE 13G/A

Kyverna Therapeutics, Inc.

Common Stock, par value $0.00001 per share · CUSIP: 501976104

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Northpond Ventures III, LP

  Shares: 2,805,426.00 · Class: 4.9%

• Northpond Ventures III GP, LLC

  Shares: 2,805,426.00 · Class: 4.9%

• Northpond Ventures, LP

  Shares: 450,000.00 · Class: 0.8%

• Northpond Ventures GP, LLC

  Shares: 450,000.00 · Class: 0.8%

• NPV Listed, LLC

  Shares: 211,400.00 · Class: 0.4%

• Northpond Ventures, LLC

  Shares: 211,400.00 · Class: 0.4%

• Michael P. Rubin

  Shares: 3,466,826.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.